Leadership Overview
OPKO Health has 7 executives leading key functions including strategy, finance, marketing, and operations.
Driven by innovation, OPKO Health is dedicated to advancing healthcare through integrated pharmaceutical and diagnostic solutions, impacting serious diseases globally.
Driven by innovation, OPKO Health is dedicated to advancing healthcare through integrated pharmaceutical and diagnostic solutions, impacting serious diseases globally.
Leadership Roles at OPKO Health
Phillip Frost - Chief Executive Officer & Chairman
Phillip Frost, the Chief Executive Officer & Chairman at OPKO Health, directs the overarching corporate strategy and governance. Frost guides the company's expansion in both its pharmaceutical and diagnostic segments, ensuring alignment with long-term growth objectives. This leadership role involves setting the vision for the discovery, development, and commercialization of novel medicines and advanced diagnostic services. Overseeing global operations, Phillip Frost ensures the integration of diverse business units to maximize market impact and patient benefit. The Chairman's responsibilities include fostering innovation across the organization and maintaining strong relationships with stakeholders, driving OPKO Health's mission to address serious diseases through cutting-edge healthcare solutions.

Charles Bishop - Chief Executive Officer, OPKO Renal
Charles Bishop, the Chief Executive Officer, OPKO Renal at OPKO Health, directs the strategic vision and operational execution for the company's renal division. Bishop oversees the development and commercialization of treatments and diagnostic services specifically targeting kidney-related diseases. This leadership role involves driving innovation within the renal therapeutic area and expanding market access for OPKO Health's specialized offerings. Overseeing the OPKO Renal business unit, Charles Bishop ensures alignment with the broader corporate strategy while fostering a focused approach to patient care and clinical outcomes. The CEO's responsibilities include managing key partnerships and advancing the pipeline of novel therapies and diagnostic tools for renal patients.
Alfredo Kaffie - Chief Financial Officer
Alfredo Kaffie, the Chief Financial Officer at OPKO Health, manages all financial operations and strategic financial planning. Kaffie oversees budgeting, forecasting, and capital allocation to support the company's pharmaceutical and diagnostic initiatives. This critical role involves ensuring financial stability and optimizing resource deployment across domestic and international markets. Alfredo Kaffie directs the treasury functions, manages investor relations, and ensures compliance with all financial regulations. By providing robust financial oversight, Kaffie enables OPKO Health to pursue its development pipeline and commercialization efforts effectively, contributing directly to the company's sustained growth and market position.
Adam Logal - Senior Vice President, Chief Financial Officer, Chief Accounting Officer and Treasurer
Adam Logal, the Senior Vice President, Chief Financial Officer, Chief Accounting Officer and Treasurer at OPKO Health, holds comprehensive responsibility for financial integrity and fiscal management. Logal oversees all accounting functions, ensuring accurate financial reporting and compliance with regulatory standards. This multifaceted role involves managing the company's treasury operations, including cash management and capital structure optimization, to support OPKO Health's strategic objectives. Overseeing financial planning and analysis, Adam Logal provides critical insights to guide investment decisions in pharmaceutical development and diagnostic services. The Treasurer's duties extend to managing banking relationships and ensuring the company's financial resources are effectively deployed across its global operations.

Adam Ali - Chief Marketing Officer & Team Leader (US)
Adam Ali, the Chief Marketing Officer & Team Leader (US) at OPKO Health, spearheads the marketing strategies and execution within the United States. Ali directs the development and implementation of campaigns for OPKO Health's pharmaceutical products and diagnostic services, focusing on market penetration and brand awareness. This leadership position involves analyzing market trends and identifying opportunities to enhance customer engagement. Overseeing the US marketing team, Adam Ali ensures cohesive messaging and effective outreach to healthcare providers and patients. The role requires close collaboration with sales and product development to align marketing efforts with commercial objectives, driving demand and supporting the company's overall business development.
Anhar Hussain - Chief Marketing Officer & Manager, US Marketing
Anhar Hussain, the Chief Marketing Officer & Manager, US Marketing at OPKO Health, drives targeted marketing initiatives across the United States. Hussain focuses on specific product lines and diagnostic services, developing tailored strategies to reach key demographics and healthcare professionals. This role involves managing marketing budgets and evaluating the effectiveness of campaigns to ensure optimal return on investment. Overseeing US marketing operations, Anhar Hussain collaborates with cross-functional teams to integrate marketing efforts with sales objectives and product launches. The position demands a deep understanding of the healthcare market to effectively communicate the value proposition of OPKO Health's offerings and expand its market reach.
MengChen Zhang - Chief Marketing Officer & Team Leader (US)
MengChen Zhang, the Chief Marketing Officer & Team Leader (US) at OPKO Health, leads strategic marketing efforts within the United States. Zhang directs the planning and execution of comprehensive marketing programs designed to elevate OPKO Health's presence in the pharmaceutical and diagnostics sectors. This leadership function involves identifying emerging market opportunities and developing innovative approaches to engage target audiences. Overseeing the US marketing team, MengChen Zhang ensures the consistent delivery of brand messaging and the successful promotion of the company's diverse portfolio. The role requires close alignment with research and development to translate scientific advancements into compelling market narratives, supporting sustained business growth.
Explore Leadership Teams in Manufacturing
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
Company Leadership

JS
21st Century Vitamins operates as a globally recognized manufacturer and distributor of dietary supplements, positioned within the broader health and wellness industry. The company, through its parent entity 21st Century HealthCare, Inc., focuses on developing, producing, and delivering a wide range of vitamins, minerals, herbal supplements, and specialty nutritional products designed to support everyday health and well-being. With a history spanning more than three decades, the organization has established itself as a trusted and accessible brand in the consumer healthcare market. At its core, the company functions as both a manufacturer and a direct-to-consumer wellness provider. It produces an extensive portfolio of dietary supplements that cater to diverse health needs, including general nutrition, immune support, cardiovascular health, digestive wellness, sports nutrition, and beauty supplements. Its offerings range from traditional multivitamins and single-nutrient formulations to advanced blends such as amino acids, probiotics, and plant-based supplements. This breadth of product categories reflects the companys strategy of addressing a wide spectrum of consumer health requirements through scientifically formulated solutions.
Company Leadership SS
FC
KW
Tabuk Pharmaceuticals is a generic pharmaceutical company that delivers quality cost-effective prices in the regulated markets of the MENA region. The company provides to the major therapeutic areas of GI and diabetes, cardiovascular, musculoskeletal, respiratory, infection, and the central nervous system pharmaceuticals.
Company Leadership IS
DB

HR
Vanda Pharmaceuticals, founded in 2003, is a biopharmaceutical research and development company focused on creating innovative medicines to improve patient lives. The company leverages advanced technologies including genetics and genomics to guide drug discovery, clinical trials, and commercial strategies. Vanda Pharmaceuticals specializes in developing novel therapeutic approaches and delivery methods for their pharmaceutical products. With operations across North America, Europe, and Asia, the company maintains a global presence in the pharmaceutical industry while continuing to advance medical research and drug development for various health conditions.
Company Leadership BA

PJ
JW